Innovating Transplantation,
Accelerating Research
Technology
The Apersys technology, backed by preclinical and first-in-human data, shows promise in preserving and restoring livers once deemed unfit for transplant.
About Us
Our team combines world leading
science in liver transplantation with
in-depth entrepreneurial expertise in medical devices.
Innovation
Discover the latest news, from the FDA Breakthrough Devices Designation to the recent publications in liver defatting.
Supported by
